<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-01-01" modified="2020-10-07" version="245">
<accession>P06733</accession>
<accession>B2RD59</accession>
<accession>P22712</accession>
<accession>Q16704</accession>
<accession>Q4TUS4</accession>
<accession>Q53FT9</accession>
<accession>Q53HR3</accession>
<accession>Q658M5</accession>
<accession>Q6GMP2</accession>
<accession>Q71V37</accession>
<accession>Q7Z3V6</accession>
<accession>Q8WU71</accession>
<accession>Q96GV1</accession>
<accession>Q9BT62</accession>
<accession>Q9UCH6</accession>
<accession>Q9UM55</accession>
<name>ENOA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Alpha-enolase</fullName>
<ecNumber evidence="18 26">4.2.1.11</ecNumber>
</recommendedName>
<alternativeName>
<fullName>2-phospho-D-glycerate hydro-lyase</fullName>
</alternativeName>
<alternativeName>
<fullName>C-myc promoter-binding protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Enolase 1</fullName>
</alternativeName>
<alternativeName>
<fullName>MBP-1</fullName>
</alternativeName>
<alternativeName>
<fullName>MPB-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Non-neural enolase</fullName>
<shortName>NNE</shortName>
</alternativeName>
<alternativeName>
<fullName>Phosphopyruvate hydratase</fullName>
</alternativeName>
<alternativeName>
<fullName>Plasminogen-binding protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">ENO1</name>
<name type="synonym">ENO1L1</name>
<name type="synonym">MBPB1</name>
<name type="synonym">MPB1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="6741" last="6745">
<title>Molecular cloning and nucleotide sequence of a full-length cDNA for human alpha enolase.</title>
<authorList>
<person name="Giallongo A."/>
<person name="Feo S."/>
<person name="Moore R."/>
<person name="Croce C.M."/>
<person name="Showe L.C."/>
</authorList>
<dbReference type="PubMed" id="3529090"/>
<dbReference type="DOI" id="10.1073/pnas.83.18.6741"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-ENOLASE)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="Eur. J. Biochem." volume="190" first="567" last="573">
<title>Structure of the human gene for alpha-enolase.</title>
<authorList>
<person name="Giallongo A."/>
<person name="Oliva D."/>
<person name="Cali L."/>
<person name="Barba G."/>
<person name="Barbieri G."/>
<person name="Feo S."/>
</authorList>
<dbReference type="PubMed" id="2373081"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1990.tb15611.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM ALPHA-ENOLASE)</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="2154" last="2161">
<title>Cloning and characterization of a human c-myc promoter-binding protein.</title>
<authorList>
<person name="Ray R."/>
<person name="Miller D.M."/>
</authorList>
<dbReference type="PubMed" id="2005901"/>
<dbReference type="DOI" id="10.1128/mcb.11.4.2154"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM MBP-1)</scope>
<scope>FUNCTION</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1995" name="J. Autoimmun." volume="8" first="931" last="945">
<title>Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis.</title>
<authorList>
<person name="Walter M."/>
<person name="Berg H."/>
<person name="Leidenberger F.A."/>
<person name="Schweppe K.W."/>
<person name="Northemann W."/>
</authorList>
<dbReference type="PubMed" id="8824716"/>
<dbReference type="DOI" id="10.1016/s0896-8411(95)80027-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA-ENOLASE)</scope>
<scope>MARKER FOR ENDOMETRIOSIS</scope>
<source>
<tissue>Endometrium</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-ENOLASE)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-ENOLASE)</scope>
<source>
<tissue>Umbilical cord blood</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-ENOLASE)</scope>
<source>
<tissue>Adipose tissue</tissue>
<tissue>Kidney proximal tubule</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-ENOLASE)</scope>
<source>
<tissue>Retina</tissue>
<tissue>Stomach</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2005-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LYS-177</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-ENOLASE)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Eye</tissue>
<tissue>Lung</tissue>
<tissue>Ovary</tissue>
<tissue>Placenta</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Electrophoresis" volume="18" first="605" last="613">
<title>A two-dimensional gel database of human colon carcinoma proteins.</title>
<authorList>
<person name="Ji H."/>
<person name="Reid G.E."/>
<person name="Moritz R.L."/>
<person name="Eddes J.S."/>
<person name="Burgess A.W."/>
<person name="Simpson R.J."/>
</authorList>
<dbReference type="PubMed" id="9150948"/>
<dbReference type="DOI" id="10.1002/elps.1150180344"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-9 (ISOFORM ALPHA-ENOLASE)</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="submission" date="2009-03" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lilla S."/>
<person name="Zebisch A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-28; 65-80; 121-162; 234-253; 270-281; 331-394 AND 407-420</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT SER-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Vishwanath V."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 16-28; 33-50; 93-103; 106-120; 163-179; 184-193; 203-221; 240-253; 257-262; 270-281; 286-326; 336-394 AND 407-412</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Genomics" volume="50" first="187" last="198">
<title>Molecular cloning and expression analysis of five novel genes in chromosome 1p36.</title>
<authorList>
<person name="Onyango P."/>
<person name="Lubyova B."/>
<person name="Gardellin P."/>
<person name="Kurzbauer R."/>
<person name="Weith A."/>
</authorList>
<dbReference type="PubMed" id="9653645"/>
<dbReference type="DOI" id="10.1006/geno.1997.5186"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 166-434</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1997" name="Genome Res." volume="7" first="353" last="358">
<title>Large-scale concatenation cDNA sequencing.</title>
<authorList>
<person name="Yu W."/>
<person name="Andersson B."/>
<person name="Worley K.C."/>
<person name="Muzny D.M."/>
<person name="Ding Y."/>
<person name="Liu W."/>
<person name="Ricafrente J.Y."/>
<person name="Wentland M.A."/>
<person name="Lennon G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="9110174"/>
<dbReference type="DOI" id="10.1101/gr.7.4.353"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 171-434</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="1992" name="Cytotechnology" volume="10" first="137" last="146">
<title>Purification and characterization of immunoglobulin production stimulating factor-II beta derived from Namalwa cells.</title>
<authorList>
<person name="Sugahara T."/>
<person name="Nakajima H."/>
<person name="Shirahata S."/>
<person name="Murakami H."/>
</authorList>
<dbReference type="PubMed" id="1369209"/>
<dbReference type="DOI" id="10.1007/bf00570890"/>
</citation>
<scope>PROTEIN SEQUENCE OF 203-228</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>PATHWAY</scope>
<source>
<tissue>Lymphoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="1994" name="Enzyme Protein" volume="48" first="37" last="44">
<title>Induced expression of alpha-enolase in differentiated diffuse large cell lymphoma.</title>
<authorList>
<person name="Mohamad R.M."/>
<person name="Hamdan M.Y."/>
<person name="Maki A."/>
<person name="Al-Katib A."/>
</authorList>
<dbReference type="PubMed" id="7787969"/>
<dbReference type="DOI" id="10.1159/000474967"/>
</citation>
<scope>PROTEIN SEQUENCE OF 270-281 AND 307-321</scope>
<scope>INDUCTION IN DIFFUSE LARGE CELL LYMPHOMA</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="2880" last="2886">
<title>Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation.</title>
<authorList>
<person name="Ghosh A.K."/>
<person name="Steele R."/>
<person name="Ray R.B."/>
</authorList>
<dbReference type="PubMed" id="10082554"/>
<dbReference type="DOI" id="10.1128/mcb.19.4.2880"/>
</citation>
<scope>FUNCTION OF MBP1</scope>
<scope>IDENTIFICATION OF REPRESSOR DOMAINS</scope>
<scope>MUTAGENESIS OF LEU-384 AND LEU-388</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="FEBS Lett." volume="473" first="47" last="52">
<title>ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1).</title>
<authorList>
<person name="Feo S."/>
<person name="Arcuri D."/>
<person name="Piddini E."/>
<person name="Passantino R."/>
<person name="Giallongo A."/>
</authorList>
<dbReference type="PubMed" id="10802057"/>
<dbReference type="DOI" id="10.1016/s0014-5793(00)01494-0"/>
</citation>
<scope>FUNCTION AS A C-MYC TRANSCRIPTIONAL REPRESSOR</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2003" name="Am. J. Hematol." volume="72" first="234" last="242">
<title>Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-enolase.</title>
<authorList>
<person name="Lopez-Alemany R."/>
<person name="Longstaff C."/>
<person name="Hawley S."/>
<person name="Mirshahi M."/>
<person name="Fabregas P."/>
<person name="Jardi M."/>
<person name="Merton E."/>
<person name="Miles L.A."/>
<person name="Felez J."/>
</authorList>
<dbReference type="PubMed" id="12666133"/>
<dbReference type="DOI" id="10.1002/ajh.10299"/>
</citation>
<scope>FUNCTION IN PLASMINOGEN ACTIVATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1997" name="Thromb. Haemost." volume="78" first="1097" last="1103">
<title>Identification of an epitope of alpha-enolase (a candidate plasminogen receptor) by phage display.</title>
<authorList>
<person name="Arza B."/>
<person name="Felez J."/>
<person name="Lopez-Alemany R."/>
<person name="Miles L.A."/>
<person name="Munoz-Canoves P."/>
</authorList>
<dbReference type="PubMed" id="9308760"/>
</citation>
<scope>INTERACTION WITH PLG</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1998" name="J. Autoimmun." volume="11" first="671" last="677">
<title>Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.</title>
<authorList>
<person name="Adamus G."/>
<person name="Amundson D."/>
<person name="Seigel G.M."/>
<person name="Machnicki M."/>
</authorList>
<dbReference type="PubMed" id="9878089"/>
<dbReference type="DOI" id="10.1006/jaut.1998.0239"/>
</citation>
<scope>EPITOPE MAPPING</scope>
<scope>ASSOCIATION WITH CAR</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="5958" last="5965">
<title>Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene.</title>
<authorList>
<person name="Subramanian A."/>
<person name="Miller D.M."/>
</authorList>
<dbReference type="PubMed" id="10681589"/>
<dbReference type="DOI" id="10.1074/jbc.275.8.5958"/>
</citation>
<scope>IDENTIFICATION OF MBP1 AS AN ALPHA-ENOLASE ALTERNATIVE INITIATION PRODUCT</scope>
<scope>MUTAGENESIS OF MET-94 AND MET-97</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2001" name="Cell. Mol. Life Sci." volume="58" first="902" last="920">
<title>Multifunctional alpha-enolase: its role in diseases.</title>
<authorList>
<person name="Pancholi V."/>
</authorList>
<dbReference type="PubMed" id="11497239"/>
<dbReference type="DOI" id="10.1007/pl00000910"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="655" last="662">
<title>A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1.</title>
<authorList>
<person name="Ghosh A.K."/>
<person name="Majumder M."/>
<person name="Steele R."/>
<person name="White R.A."/>
<person name="Ray R.B."/>
</authorList>
<dbReference type="PubMed" id="11134351"/>
<dbReference type="DOI" id="10.1128/mcb.21.2.655-662.2001"/>
</citation>
<scope>INTERACTION WITH TRAPPC2B (ISOFORM MBP-1)</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2002" name="FEBS Lett." volume="528" first="197" last="202">
<title>Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy.</title>
<authorList>
<person name="Ochi H."/>
<person name="Horiuchi I."/>
<person name="Araki N."/>
<person name="Toda T."/>
<person name="Araki T."/>
<person name="Sato K."/>
<person name="Murai H."/>
<person name="Osoegawa M."/>
<person name="Yamada T."/>
<person name="Okamura K."/>
<person name="Ogino T."/>
<person name="Mizumoto K."/>
<person name="Yamashita H."/>
<person name="Saya H."/>
<person name="Kira J."/>
</authorList>
<dbReference type="PubMed" id="12297304"/>
<dbReference type="DOI" id="10.1016/s0014-5793(02)03307-0"/>
</citation>
<scope>IDENTIFICATION AS AN AUTOANTIGEN IN HASHIMOTO ENCEPHALOPATHY</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="496" last="506">
<title>Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.</title>
<authorList>
<person name="Giannakopoulos N.V."/>
<person name="Luo J.K."/>
<person name="Papov V."/>
<person name="Zou W."/>
<person name="Lenschow D.J."/>
<person name="Jacobs B.S."/>
<person name="Borden E.C."/>
<person name="Li J."/>
<person name="Virgin H.W."/>
<person name="Zhang D.E."/>
</authorList>
<dbReference type="PubMed" id="16139798"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.132"/>
</citation>
<scope>ISGYLATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44 AND TYR-287</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Cell. Microbiol." volume="8" first="565" last="580">
<title>Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection.</title>
<authorList>
<person name="Leong W.F."/>
<person name="Chow V.T."/>
</authorList>
<dbReference type="PubMed" id="16548883"/>
<dbReference type="DOI" id="10.1111/j.1462-5822.2005.00644.x"/>
</citation>
<scope>INDUCTION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="10735" last="10740">
<title>HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets.</title>
<authorList>
<person name="Wong J.J."/>
<person name="Pung Y.F."/>
<person name="Sze N.S."/>
<person name="Chin K.C."/>
</authorList>
<dbReference type="PubMed" id="16815975"/>
<dbReference type="DOI" id="10.1073/pnas.0600397103"/>
</citation>
<scope>ISGYLATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254 AND SER-263</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-272</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-64; LYS-71; LYS-89; LYS-126; LYS-193; LYS-199; LYS-228; LYS-233; LYS-256; LYS-281; LYS-285 AND LYS-420</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Mol. Cell. Proteomics" volume="10" first="M111.012658.01" last="M111.012658.12">
<title>The first identification of lysine malonylation substrates and its regulatory enzyme.</title>
<authorList>
<person name="Peng C."/>
<person name="Lu Z."/>
<person name="Xie Z."/>
<person name="Cheng Z."/>
<person name="Chen Y."/>
<person name="Tan M."/>
<person name="Luo H."/>
<person name="Zhang Y."/>
<person name="He W."/>
<person name="Yang K."/>
<person name="Zwaans B.M."/>
<person name="Tishkoff D."/>
<person name="Ho L."/>
<person name="Lombard D."/>
<person name="He T.C."/>
<person name="Dai J."/>
<person name="Verdin E."/>
<person name="Ye Y."/>
<person name="Zhao Y."/>
</authorList>
<dbReference type="PubMed" id="21908771"/>
<dbReference type="DOI" id="10.1074/mcp.m111.012658"/>
</citation>
<scope>MALONYLATION AT LYS-233 AND LYS-420</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2012" name="J. Proteome Res." volume="11" first="4733" last="4743">
<title>Resveratrol-induced changes of the human adipocyte secretion profile.</title>
<authorList>
<person name="Rosenow A."/>
<person name="Noben J.P."/>
<person name="Jocken J."/>
<person name="Kallendrusch S."/>
<person name="Fischer-Posovszky P."/>
<person name="Mariman E.C."/>
<person name="Renes J."/>
</authorList>
<dbReference type="PubMed" id="22905912"/>
<dbReference type="DOI" id="10.1021/pr300539b"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-254; SER-263 AND SER-272</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-263 AND SER-291</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-202</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2017" name="Nature" volume="549" first="101" last="105">
<title>CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.</title>
<authorList>
<person name="Burr M.L."/>
<person name="Sparbier C.E."/>
<person name="Chan Y.C."/>
<person name="Williamson J.C."/>
<person name="Woods K."/>
<person name="Beavis P.A."/>
<person name="Lam E.Y.N."/>
<person name="Henderson M.A."/>
<person name="Bell C.C."/>
<person name="Stolzenburg S."/>
<person name="Gilan O."/>
<person name="Bloor S."/>
<person name="Noori T."/>
<person name="Morgens D.W."/>
<person name="Bassik M.C."/>
<person name="Neeson P.J."/>
<person name="Behren A."/>
<person name="Darcy P.K."/>
<person name="Dawson S.J."/>
<person name="Voskoboinik I."/>
<person name="Trapani J.A."/>
<person name="Cebon J."/>
<person name="Lehner P.J."/>
<person name="Dawson M.A."/>
</authorList>
<dbReference type="PubMed" id="28813417"/>
<dbReference type="DOI" id="10.1038/nature23643"/>
</citation>
<scope>INTERACTION WITH CMTM6</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2018" name="Mol. Cell" volume="70" first="663" last="678">
<title>p300-mediated lysine 2-hydroxyisobutyrylation regulates glycolysis.</title>
<authorList>
<person name="Huang H."/>
<person name="Tang S."/>
<person name="Ji M."/>
<person name="Tang Z."/>
<person name="Shimada M."/>
<person name="Liu X."/>
<person name="Qi S."/>
<person name="Locasale J.W."/>
<person name="Roeder R.G."/>
<person name="Zhao Y."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="29775581"/>
<dbReference type="DOI" id="10.1016/j.molcel.2018.04.011"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>HYDROXYBUTYRYLATION AT LYS-228 AND LYS-281</scope>
<scope>MUTAGENESIS OF LYS-281</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="Acta Crystallogr. D" volume="64" first="651" last="657">
<title>Structure of human alpha-enolase (hENO1), a multifunctional glycolytic enzyme.</title>
<authorList>
<person name="Kang H.J."/>
<person name="Jung S.K."/>
<person name="Kim S.J."/>
<person name="Chung S.J."/>
</authorList>
<dbReference type="PubMed" id="18560153"/>
<dbReference type="DOI" id="10.1107/s0907444908008561"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 2-434</scope>
<scope>SUBUNIT</scope>
<scope>COFACTOR</scope>
<scope>METAL-BINDING SITES</scope>
</reference>
<comment type="function">
<text evidence="15 17 18 23 26">Glycolytic enzyme the catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate (PubMed:29775581, PubMed:1369209). In addition to glycolysis, involved in various processes such as growth control, hypoxia tolerance and allergic responses (PubMed:2005901, PubMed:10802057, PubMed:12666133, PubMed:29775581). May also function in the intravascular and pericellular fibrinolytic system due to its ability to serve as a receptor and activator of plasminogen on the cell surface of several cell-types such as leukocytes and neurons (PubMed:12666133). Stimulates immunoglobulin production (PubMed:1369209).</text>
</comment>
<comment type="function">
<text evidence="13">MBP1 binds to the myc promoter and acts as a transcriptional repressor. May be a tumor suppressor.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="18 26">
<text>(2R)-2-phosphoglycerate = H2O + phosphoenolpyruvate</text>
<dbReference type="Rhea" id="RHEA:10164"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:58289"/>
<dbReference type="ChEBI" id="CHEBI:58702"/>
<dbReference type="EC" id="4.2.1.11"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="22">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<text evidence="22">Binds two Mg(2+) per subunit. Required for catalysis and for stabilizing the dimer.</text>
</comment>
<comment type="biophysicochemical properties">
<phDependence>
<text evidence="18">Enolase activity is lost above pH 9.0. Immunoglobulin production stimulating activity is retained at pH 13.0.</text>
</phDependence>
</comment>
<comment type="pathway" evidence="33">
<text>Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5.</text>
</comment>
<comment type="subunit">
<text evidence="12 16 22 25 28">Mammalian enolase is composed of 3 isozyme subunits, alpha, beta and gamma, which can form homodimers or heterodimers which are cell-type and development-specific (PubMed:18560153). ENO1 interacts with PLG in the neuronal plasma membrane and promotes its activation. The C-terminal lysine is required for this binding (PubMed:9308760). Isoform MBP-1 interacts with TRAPPC2B (PubMed:11134351). Interacts with ENO4 and PGAM2 (By similarity). Interacts with CMTM6 (PubMed:28813417).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353877">
<id>P06733</id>
</interactant>
<interactant intactId="EBI-1637793">
<id>P22303</id>
<label>ACHE</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353877">
<id>P06733</id>
</interactant>
<interactant intactId="EBI-358311">
<id>P12004</id>
<label>PCNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353877">
<id>P06733</id>
</interactant>
<interactant intactId="EBI-681210">
<id>Q8WZ42</id>
<label>TTN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353877">
<id>P06733</id>
</interactant>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353877">
<id>P06733</id>
</interactant>
<interactant intactId="EBI-400263">
<id>Q60823</id>
<label>Akt2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cytoplasm</location>
<location evidence="15">Myofibril</location>
<location evidence="15">Sarcomere</location>
<location evidence="15">M line</location>
</subcellularLocation>
<text>Can translocate to the plasma membrane in either the homodimeric (alpha/alpha) or heterodimeric (alpha/gamma) form. ENO1 is localized to the M line.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform MBP-1</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative initiation"/>
<isoform>
<id>P06733-1</id>
<name>alpha-enolase</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P06733-2</id>
<name>MBP-1</name>
<sequence type="described" ref="VSP_018725"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>The alpha/alpha homodimer is expressed in embryo and in most adult tissues. The alpha/beta heterodimer and the beta/beta homodimer are found in striated muscle, and the alpha/gamma heterodimer and the gamma/gamma homodimer in neurons.</text>
</comment>
<comment type="developmental stage">
<text>During ontogenesis, there is a transition from the alpha/alpha homodimer to the alpha/beta heterodimer in striated muscle cells, and to the alpha/gamma heterodimer in nerve cells.</text>
</comment>
<comment type="induction">
<text evidence="20 27">Induced in diffuse large cell lymphoma (DLCL) after treatment with the natural biological agent, Bryo1. Up-regulated in response to enterovirus 71 (EV71) infection (at protein level).</text>
</comment>
<comment type="PTM">
<text evidence="19 21">ISGylated.</text>
</comment>
<comment type="PTM">
<text evidence="26">Lysine 2-hydroxyisobutyrylation (Khib) by p300/EP300 activates the phosphopyruvate hydratase activity.</text>
</comment>
<comment type="miscellaneous">
<text>Used as a diagnostic marker for many tumors and, in the heterodimeric form, alpha/gamma, as a marker for hypoxic brain injury after cardiac arrest. Also marker for endometriosis. Antibodies against alpha-enolase are present in sera from patients with cancer-associated retinopathy syndrome (CAR), a progressive blinding disease which occurs in the presence of systemic tumor growth, primarily small-cell carcinoma of the lung and other malignancies. Is identified as an autoantigen in Hashimoto encephalopathy (HE) a rare autoimmune disease associated with Hashimoto thyroiditis (HT). HT is a disorder in which destructive processes overcome the potential capacity of thyroid replacement leading to hypothyroidism.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform MBP-1</molecule>
<text evidence="32">It is uncertain whether the alternative initiation site is at Met-94 or at Met-97.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the enolase family.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAA35698" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAA35698" version="1"/>
</conflict>
<text>Sequencing errors.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/eno1/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ENO1ID40453ch1p36.html"/>
</comment>
<dbReference type="EC" id="4.2.1.11" evidence="18 26"/>
<dbReference type="EMBL" id="M14328">
<property type="protein sequence ID" value="AAA52387.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X16288">
<property type="protein sequence ID" value="CAA34360.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X16289">
<property type="protein sequence ID" value="CAA34360.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X16290">
<property type="protein sequence ID" value="CAA34360.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55914">
<property type="protein sequence ID" value="AAA35698.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X84907">
<property type="protein sequence ID" value="CAA59331.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007163">
<property type="protein sequence ID" value="AAP35827.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315417">
<property type="protein sequence ID" value="BAG37806.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL833741">
<property type="protein sequence ID" value="CAH56247.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BX537400">
<property type="protein sequence ID" value="CAD97642.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK222517">
<property type="protein sequence ID" value="BAD96237.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223192">
<property type="protein sequence ID" value="BAD96912.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ056744">
<property type="protein sequence ID" value="AAY43128.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL139415">
<property type="protein sequence ID" value="CAC42425.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471130">
<property type="protein sequence ID" value="EAW71604.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001810">
<property type="protein sequence ID" value="AAH01810.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004325">
<property type="protein sequence ID" value="AAH04325.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC004458">
<property type="protein sequence ID" value="AAH04458.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC009218">
<property type="protein sequence ID" value="AAH09218.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC009912">
<property type="protein sequence ID" value="AAH09912.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011130">
<property type="protein sequence ID" value="AAH11130.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015641">
<property type="protein sequence ID" value="AAH15641.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021166">
<property type="protein sequence ID" value="AAH21166.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC022545">
<property type="protein sequence ID" value="AAH22545.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC027725">
<property type="protein sequence ID" value="AAH27725.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC050642">
<property type="protein sequence ID" value="AAH50642.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U88968">
<property type="protein sequence ID" value="AAC39935.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035286">
<property type="protein sequence ID" value="AAB88178.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS97.1">
<molecule id="P06733-1"/>
</dbReference>
<dbReference type="PIR" id="A39579">
<property type="entry name" value="A39579"/>
</dbReference>
<dbReference type="PIR" id="S11696">
<property type="entry name" value="A29170"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001188412.1">
<molecule id="P06733-2"/>
<property type="nucleotide sequence ID" value="NM_001201483.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001419.1">
<molecule id="P06733-1"/>
<property type="nucleotide sequence ID" value="NM_001428.3"/>
</dbReference>
<dbReference type="PDB" id="2PSN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=1-434"/>
</dbReference>
<dbReference type="PDB" id="3B97">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=2-434"/>
</dbReference>
<dbReference type="PDB" id="5JLZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="E/F=26-40"/>
</dbReference>
<dbReference type="PDB" id="5LAX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="E/F=26-40"/>
</dbReference>
<dbReference type="PDB" id="5NI9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.33"/>
<property type="chains" value="C=326-340"/>
</dbReference>
<dbReference type="PDB" id="5NIG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="C=326-340"/>
</dbReference>
<dbReference type="PDB" id="5OCK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=5-21"/>
</dbReference>
<dbReference type="PDBsum" id="2PSN"/>
<dbReference type="PDBsum" id="3B97"/>
<dbReference type="PDBsum" id="5JLZ"/>
<dbReference type="PDBsum" id="5LAX"/>
<dbReference type="PDBsum" id="5NI9"/>
<dbReference type="PDBsum" id="5NIG"/>
<dbReference type="PDBsum" id="5OCK"/>
<dbReference type="SMR" id="P06733"/>
<dbReference type="BioGRID" id="108338">
<property type="interactions" value="385"/>
</dbReference>
<dbReference type="IntAct" id="P06733">
<property type="interactions" value="121"/>
</dbReference>
<dbReference type="MINT" id="P06733"/>
<dbReference type="STRING" id="9606.ENSP00000234590"/>
<dbReference type="BindingDB" id="P06733"/>
<dbReference type="ChEMBL" id="CHEMBL3298"/>
<dbReference type="DrugBank" id="DB11638">
<property type="generic name" value="Artenimol"/>
</dbReference>
<dbReference type="DrugBank" id="DB09130">
<property type="generic name" value="Copper"/>
</dbReference>
<dbReference type="DrugBank" id="DB01593">
<property type="generic name" value="Zinc"/>
</dbReference>
<dbReference type="DrugBank" id="DB14487">
<property type="generic name" value="Zinc acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14533">
<property type="generic name" value="Zinc chloride"/>
</dbReference>
<dbReference type="DrugBank" id="DB14548">
<property type="generic name" value="Zinc sulfate, unspecified form"/>
</dbReference>
<dbReference type="MoonDB" id="P06733">
<property type="type" value="Predicted"/>
</dbReference>
<dbReference type="MoonProt" id="P06733"/>
<dbReference type="GlyGen" id="P06733">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="P06733"/>
<dbReference type="MetOSite" id="P06733"/>
<dbReference type="PhosphoSitePlus" id="P06733"/>
<dbReference type="SwissPalm" id="P06733"/>
<dbReference type="BioMuta" id="ENO1"/>
<dbReference type="DMDM" id="119339"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P06733"/>
<dbReference type="OGP" id="P06733"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00465248"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P06733"/>
<dbReference type="SWISS-2DPAGE" id="P06733"/>
<dbReference type="UCD-2DPAGE" id="P06733"/>
<dbReference type="CPTAC" id="CPTAC-70"/>
<dbReference type="EPD" id="P06733"/>
<dbReference type="jPOST" id="P06733"/>
<dbReference type="MassIVE" id="P06733"/>
<dbReference type="MaxQB" id="P06733"/>
<dbReference type="PaxDb" id="P06733"/>
<dbReference type="PeptideAtlas" id="P06733"/>
<dbReference type="PRIDE" id="P06733"/>
<dbReference type="ProteomicsDB" id="51919">
<molecule id="P06733-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51920">
<molecule id="P06733-2"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P06733-1">
<molecule id="P06733-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P06733-2">
<molecule id="P06733-2"/>
</dbReference>
<dbReference type="ABCD" id="P06733">
<property type="antibodies" value="5 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="4351">
<property type="antibodies" value="811 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2023"/>
<dbReference type="Ensembl" id="ENST00000234590">
<molecule id="P06733-1"/>
<property type="protein sequence ID" value="ENSP00000234590"/>
<property type="gene ID" value="ENSG00000074800"/>
</dbReference>
<dbReference type="GeneID" id="2023"/>
<dbReference type="KEGG" id="hsa:2023"/>
<dbReference type="UCSC" id="uc001apj.3">
<molecule id="P06733-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2023"/>
<dbReference type="DisGeNET" id="2023"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000074800.13"/>
<dbReference type="GeneCards" id="ENO1"/>
<dbReference type="HGNC" id="HGNC:3350">
<property type="gene designation" value="ENO1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000074800">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="172430">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P06733"/>
<dbReference type="OpenTargets" id="ENSG00000074800"/>
<dbReference type="PharmGKB" id="PA27786"/>
<dbReference type="eggNOG" id="KOG2670">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00950000182805"/>
<dbReference type="HOGENOM" id="CLU_031223_0_0_1"/>
<dbReference type="InParanoid" id="P06733"/>
<dbReference type="KO" id="K01689"/>
<dbReference type="OMA" id="GPELVGY"/>
<dbReference type="PhylomeDB" id="P06733"/>
<dbReference type="TreeFam" id="TF300391"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000074800-MONOMER"/>
<dbReference type="BRENDA" id="4.2.1.11">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P06733"/>
<dbReference type="Reactome" id="R-HSA-70171">
<property type="pathway name" value="Glycolysis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-70263">
<property type="pathway name" value="Gluconeogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9636667">
<property type="pathway name" value="Manipulation of host energy metabolism"/>
</dbReference>
<dbReference type="SABIO-RK" id="P06733"/>
<dbReference type="SIGNOR" id="P06733"/>
<dbReference type="UniPathway" id="UPA00109">
<property type="reaction ID" value="UER00187"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="2023">
<property type="hits" value="376 hits in 888 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="ENO1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P06733"/>
<dbReference type="GeneWiki" id="Alpha-enolase"/>
<dbReference type="GenomeRNAi" id="2023"/>
<dbReference type="Pharos" id="P06733">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P06733"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P06733">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000074800">
<property type="expression patterns" value="Expressed in cortex of kidney and 243 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P06733">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P06733">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0099738">
<property type="term" value="C:cell cortex region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="LIFEdb"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031430">
<property type="term" value="C:M band"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000015">
<property type="term" value="C:phosphopyruvate hydratase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0051020">
<property type="term" value="F:GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004634">
<property type="term" value="F:phosphopyruvate hydratase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0061621">
<property type="term" value="P:canonical glycolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006094">
<property type="term" value="P:gluconeogenesis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006096">
<property type="term" value="P:glycolytic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903298">
<property type="term" value="P:negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001171">
<property type="term" value="P:positive regulation of ATP biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045933">
<property type="term" value="P:positive regulation of muscle contraction"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0010756">
<property type="term" value="P:positive regulation of plasminogen activation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0032889">
<property type="term" value="P:regulation of vacuole fusion, non-autophagic"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd03313">
<property type="entry name" value="enolase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.20.20.120">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.390.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="HAMAP" id="MF_00318">
<property type="entry name" value="Enolase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000941">
<property type="entry name" value="Enolase"/>
</dbReference>
<dbReference type="InterPro" id="IPR036849">
<property type="entry name" value="Enolase-like_C_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR029017">
<property type="entry name" value="Enolase-like_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR020810">
<property type="entry name" value="Enolase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR020809">
<property type="entry name" value="Enolase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020811">
<property type="entry name" value="Enolase_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11902">
<property type="entry name" value="PTHR11902"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00113">
<property type="entry name" value="Enolase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF03952">
<property type="entry name" value="Enolase_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001400">
<property type="entry name" value="Enolase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00148">
<property type="entry name" value="ENOLASE"/>
</dbReference>
<dbReference type="SFLD" id="SFLDG00178">
<property type="entry name" value="enolase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01192">
<property type="entry name" value="Enolase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01193">
<property type="entry name" value="Enolase_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51604">
<property type="entry name" value="SSF51604"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54826">
<property type="entry name" value="SSF54826"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR01060">
<property type="entry name" value="eno"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00164">
<property type="entry name" value="ENOLASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0324">Glycolysis</keyword>
<keyword id="KW-0379">Hydroxylation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0456">Lyase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0617">Plasminogen activation</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="8 29">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Alpha-enolase" id="PRO_0000134097">
<location>
<begin position="2"/>
<end position="434"/>
</location>
</feature>
<feature type="region of interest" description="Epitope recognized by CAR and healthy patient antibodies">
<location>
<begin position="31"/>
<end position="38"/>
</location>
</feature>
<feature type="region of interest" description="Epitope recognized by CAR antibodies">
<location>
<begin position="56"/>
<end position="63"/>
</location>
</feature>
<feature type="region of interest" description="Required for repression of c-myc promoter activity">
<location>
<begin position="97"/>
<end position="237"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="11">
<location>
<begin position="370"/>
<end position="373"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with PLG" evidence="10">
<location>
<begin position="405"/>
<end position="434"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="11">
<location>
<position position="210"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="11">
<location>
<position position="343"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1" evidence="22">
<location>
<position position="40"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2" evidence="22">
<location>
<position position="245"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2" evidence="22">
<location>
<position position="293"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2" evidence="22">
<location>
<position position="318"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="11">
<location>
<position position="158"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="11">
<location>
<position position="167"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="11">
<location>
<position position="293"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="11">
<location>
<position position="318"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="11">
<location>
<position position="394"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="8 29">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="5"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="27"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="2">
<location>
<position position="44"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="12">
<location>
<position position="60"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="12">
<location>
<position position="60"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="64"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="71"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="89"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="12">
<location>
<position position="89"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="92"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="126"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="193"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="199"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="12">
<location>
<position position="202"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="26">
<location>
<position position="228"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="228"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="12">
<location>
<position position="228"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="233"/>
</location>
</feature>
<feature type="modified residue" description="N6-malonyllysine; alternate" evidence="24">
<location>
<position position="233"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 6">
<location>
<position position="254"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="256"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 6 7">
<location>
<position position="263"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location>
<position position="272"/>
</location>
</feature>
<feature type="modified residue" description="N6-(2-hydroxyisobutyryl)lysine; alternate" evidence="26">
<location>
<position position="281"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="281"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="285"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="2">
<location>
<position position="287"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="291"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="335"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="343"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="406"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="420"/>
</location>
</feature>
<feature type="modified residue" description="N6-malonyllysine; alternate" evidence="24">
<location>
<position position="420"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="12">
<location>
<position position="420"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="9">
<location>
<position position="202"/>
</location>
</feature>
<feature type="splice variant" description="In isoform MBP-1." id="VSP_018725" evidence="31">
<location>
<begin position="1"/>
<end position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11544513." id="VAR_025172" evidence="30">
<original>N</original>
<variation>K</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11544514." id="VAR_048936">
<original>P</original>
<variation>Q</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="mutagenesis site" description="MBP1 protein production. No MBP1 protein production; when associated with I-97." evidence="14">
<original>M</original>
<variation>I</variation>
<location>
<position position="94"/>
</location>
</feature>
<feature type="mutagenesis site" description="MBP1 protein production. No MBP1 protein production; when associated with I-94." evidence="14">
<original>M</original>
<variation>I</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased 2-hydroxyisobutyrylation leading to decreased phosphopyruvate hydratase activity." evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of transcriptional repression and cell growth inhibition; when associated with A-388." evidence="13">
<original>L</original>
<variation>A</variation>
<location>
<position position="384"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of transcriptional repression and cell growth inhibition; when associated with A-384." evidence="13">
<original>L</original>
<variation>A</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; CAD97642." ref="8" evidence="32">
<original>T</original>
<variation>A</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAD96237." ref="7" evidence="32">
<original>V</original>
<variation>A</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; CAD97642." ref="8" evidence="32">
<original>E</original>
<variation>G</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAD96912." ref="7" evidence="32">
<original>K</original>
<variation>R</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA59331." ref="4" evidence="32">
<original>F</original>
<variation>S</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; CAD97642." ref="8" evidence="32">
<original>S</original>
<variation>I</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="5"/>
<end position="12"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="18"/>
<end position="26"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="29"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="57"/>
<end position="59"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="63"/>
<end position="71"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="73"/>
<end position="79"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="87"/>
<end position="98"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="108"/>
<end position="125"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="130"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="147"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="156"/>
<end position="158"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="159"/>
<end position="162"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="167"/>
<end position="171"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="178"/>
<end position="200"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="220"/>
<end position="233"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="237"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="241"/>
<end position="245"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="248"/>
<end position="250"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="259"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="267"/>
<end position="269"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="273"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="289"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="301"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="313"/>
<end position="318"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="319"/>
<end position="323"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="325"/>
<end position="334"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="338"/>
<end position="342"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="344"/>
<end position="347"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="350"/>
<end position="362"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="366"/>
<end position="370"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="380"/>
<end position="387"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="391"/>
<end position="394"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="401"/>
<end position="417"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="418"/>
<end position="420"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="425"/>
<end position="427"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PSN"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15592455"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P00924"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P17182"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10082554"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10681589"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10802057"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11134351"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12666133"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1369209"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16139798"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16548883"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16815975"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18560153"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2005901"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21908771"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28813417"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29775581"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7787969"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9308760"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source ref="14"/>
</evidence>
<evidence key="30" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="31" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2005901"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<evidence key="33" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="1369209"/>
</source>
</evidence>
<sequence length="434" mass="47169" checksum="A0ED663FCC15ADA5" modified="2007-01-23" version="2">MSILKIHAREIFDSRGNPTVEVDLFTSKGLFRAAVPSGASTGIYEALELRDNDKTRYMGKGVSKAVEHINKTIAPALVSKKLNVTEQEKIDKLMIEMDGTENKSKFGANAILGVSLAVCKAGAVEKGVPLYRHIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFREAMRIGAEVYHNLKNVIKEKYGKDATNVGDEGGFAPNILENKEGLELLKTAIGKAGYTDKVVIGMDVAASEFFRSGKYDLDFKSPDDPSRYISPDQLADLYKSFIKDYPVVSIEDPFDQDDWGAWQKFTASAGIQVVGDDLTVTNPKRIAKAVNEKSCNCLLLKVNQIGSVTESLQACKLAQANGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLLRIEEELGSKAKFAGRNFRNPLAK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

